
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …

The University of Sussex is set to produce a portfolio of new cancer drugs which exploit our DNA damage response …

